Winlevi (Clascoterone) cream 1%

ApprovedActive
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
Phase 3
5
Approved
Indication / Disease

Acne Vulgaris

Conditions

Acne Vulgaris

Trial Timeline

Jul 1, 2024 → Mar 1, 2026

About Winlevi (Clascoterone) cream 1%

Winlevi (Clascoterone) cream 1% is a approved stage product being developed by Sun Pharmaceutical for Acne Vulgaris. The current trial status is active. This product is registered under clinical trial identifier NCT06425900. Target conditions include Acne Vulgaris.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT06425900ApprovedActive

Competing Products

20 competing products in Acne Vulgaris

See all competitors
ProductCompanyStageHype Score
Olumacostat Glasaretil Gel, 5.0%Eli LillyPhase 3
77
HT-001 2% Topical Gel + HT-001 1% Topical Gel + HT-001 0.5% Topical Gel + HT-001 PlaceboHoth TherapeuticsPhase 2
44
Trifarotene Cream 0.005% + AKLIEF® Cream (Trifarotene 0.005%) US REFERENCE LISTED DRUG + AKLIEF® Cream (Trifarotene 50 mcg/g) CANADIAN REFERENCE PRODUCT + PlaceboSun PharmaceuticalPhase 1
33
Tretinoin Gel Microsphere, 0.1% + RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% + Placebo ControlSun PharmaceuticalPhase 1
33
Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5% + Acanya® Gel, 1.2%/2.5% + Vehicle of test productSun PharmaceuticalPhase 1
33
Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel + Duac® Topical Gel + Placebo Topical GelSun PharmaceuticalPhase 1
33
Adapalene Gel 0.1% + Placebo Control + Differin® Gel (Adapalene 0.1%, Galderma)Sun PharmaceuticalPhase 1
33
Trifarotene Cream 0.005% + Placebo + AKLIEF® Cream (Trifarotene 0.005%, Galderma Laboratories)Sun PharmaceuticalPhase 1
33
Adapalene/BP gel, 0.3%/2.5% + EPIDUO® FORTE + PlaceboSun PharmaceuticalPhase 1
33
ADPS topical product + Placebo ControlSun PharmaceuticalPhase 2
52
IsotretinoinSun PharmaceuticalApproved
85
Adapalene Gel 0.3% + Differin® + PlaceboSun PharmaceuticalPhase 1
33
CLPG Topical Gel 1% + Clindamycin + PlaceboSun PharmaceuticalPhase 1
33
Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% + Epiduo® Gel + PlaceboSun PharmaceuticalPhase 1
33
Test. + Aczone Gel 5% + PlaceboSun PharmaceuticalPhase 1
33
Clindamycin and Benzoyl Peroxide Gel 1%5% + BenzaClin® Topical Gel + PlaceboSun PharmaceuticalPhase 1
33
Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% + Onexton™ Gel + PlaceboSun PharmaceuticalPhase 1
33
Clindamycin Phosphate + Clindamycin Phosphate RLD + PlacebosSun PharmaceuticalPhase 1
33
Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% + CABTREO Topical Gel + Placebo ControlSun PharmaceuticalPhase 1
33
Tretinoin cream, 0.05% + RETIN-A® (tretinoin) cream, 0.05% + Vehicle of the test productSun PharmaceuticalPhase 1
33